Mangoceuticals (MGRX) Competitors $2.57 +0.47 (+22.38%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.45 -0.12 (-4.82%) As of 04/17/2025 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRX vs. CCM, MRAI, ENZ, BRTX, KDLY, ATPC, SSY, OTRK, DHAC, and ATIPShould you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include Concord Medical Services (CCM), Marpai (MRAI), Enzo Biochem (ENZ), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Agape ATP (ATPC), SunLink Health Systems (SSY), Ontrak (OTRK), Digital Health Acquisition (DHAC), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry. Mangoceuticals vs. Concord Medical Services Marpai Enzo Biochem BioRestorative Therapies Kindly MD Agape ATP SunLink Health Systems Ontrak Digital Health Acquisition ATI Physical Therapy Mangoceuticals (NASDAQ:MGRX) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their community ranking, risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends. Does the MarketBeat Community favor MGRX or CCM? Concord Medical Services received 197 more outperform votes than Mangoceuticals when rated by MarketBeat users. CompanyUnderperformOutperformMangoceuticalsN/AN/AConcord Medical ServicesOutperform Votes19758.98% Underperform Votes13741.02% Do institutionals & insiders hold more shares of MGRX or CCM? 56.7% of Mangoceuticals shares are held by institutional investors. 16.0% of Mangoceuticals shares are held by insiders. Comparatively, 46.5% of Concord Medical Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better valuation & earnings, MGRX or CCM? Mangoceuticals has higher earnings, but lower revenue than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMangoceuticals$615.87K21.57-$9.21M-$4.85-0.53Concord Medical Services$471.70M0.04-$41.93MN/AN/A Which has more risk & volatility, MGRX or CCM? Mangoceuticals has a beta of 2.41, meaning that its stock price is 141% more volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -0.64, meaning that its stock price is 164% less volatile than the S&P 500. Does the media refer more to MGRX or CCM? In the previous week, Mangoceuticals had 1 more articles in the media than Concord Medical Services. MarketBeat recorded 2 mentions for Mangoceuticals and 1 mentions for Concord Medical Services. Mangoceuticals' average media sentiment score of 0.21 beat Concord Medical Services' score of 0.00 indicating that Mangoceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mangoceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Concord Medical Services 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is MGRX or CCM more profitable? Concord Medical Services has a net margin of 0.00% compared to Mangoceuticals' net margin of -1,237.00%. Concord Medical Services' return on equity of 0.00% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mangoceuticals-1,237.00% -138.00% -118.88% Concord Medical Services N/A N/A N/A SummaryMangoceuticals and Concord Medical Services tied by winning 6 of the 12 factors compared between the two stocks. Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRX vs. The Competition Export to ExcelMetricMangoceuticalshealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.28M$1.89B$5.30B$7.35BDividend YieldN/A7.10%5.12%4.30%P/E Ratio-0.4414.7121.8017.80Price / Sales21.574.18379.9697.74Price / CashN/A9.3238.2634.64Price / Book4.763.996.443.98Net Income-$9.21M$87.49M$3.21B$247.73M7 Day Performance64.22%-2.27%2.87%1.81%1 Month Performance-29.01%-12.40%-8.63%-6.98%1 Year Performance-96.19%-32.19%11.46%1.37% Mangoceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRXMangoceuticals0.5209 of 5 stars$2.57+22.4%N/A-95.9%$13.28M$615,873.00-0.443Short Interest ↑CCMConcord Medical Services0.3967 of 5 stars$4.20-5.4%N/A-33.7%$18.23M$471.70M0.00970Analyst ForecastNews CoverageGap DownMRAIMarpaiN/A$1.00+4.2%N/A-57.7%$14.90M$34.87M-0.38150Gap UpENZEnzo Biochem0.5657 of 5 stars$0.28-2.4%N/A-71.9%$14.83M$29.09M0.00520Analyst ForecastGap DownHigh Trading VolumeBRTXBioRestorative Therapies3.5876 of 5 stars$1.70-0.3%$18.00+961.9%+25.9%$12.72M$377,000.00-1.117Short Interest ↓KDLYKindly MD0.1646 of 5 stars$1.43-3.4%N/AN/A$8.62M$2.72M-2.17N/ANews CoverageGap UpATPCAgape ATP0.9623 of 5 stars$1.54+26.2%N/A-59.4%$6.15M$1.32M-2.1140Gap UpSSYSunLink Health SystemsN/A$0.86-2.5%N/A+34.1%$6.02M$31.23M6.111,376OTRKOntrak2.8277 of 5 stars$1.43-1.8%$45.00+3,057.9%-74.3%$6.01M$11.24M-0.13250Earnings ReportShort Interest ↓DHACDigital Health AcquisitionN/A$1.14-4.2%N/A-90.6%$4.11MN/A0.002,021News CoverageATIPATI Physical TherapyN/A$0.89-4.3%N/A-78.4%$3.94M$741.86M-0.055,600Gap Down Related Companies and Tools Related Companies CCM Alternatives MRAI Alternatives ENZ Alternatives BRTX Alternatives KDLY Alternatives ATPC Alternatives SSY Alternatives OTRK Alternatives DHAC Alternatives ATIP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRX) was last updated on 4/18/2025 by MarketBeat.com Staff From Our Partners100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MGRX Stock Free MGRX Stock Alerts